GLP-1RA和心血管疾病:内皮是不是一个相关的平台?
Rossella Menghini1, Viviana Casagrande2, Stefano Rizza2,3
1Departments of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. menghini@med.uniroma2.it.
Acta diabetologica
|July 4, 2023
概括
类似葡萄糖类1受体激动剂 (GLP-1RAs) 改善内皮功能,降低心血管疾病风险. 这些药物通过直接的血管作用和间接的代谢调节提供好处.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高血糖会损害内皮功能,增加动脉样硬化心血管疾病 (ASCVD) 的风险.
- 类似葡萄糖类1受体激动剂 (GLP-1RAs) 是控制血糖水平的关键药物治疗方法.
研究的目的:
- 审查GLP-1RAs对心血管的影响.
- 探索GLP-1RA介导的内皮功能和ASCVD改善背后的分子机制.
- 突出GLP-1RAs在控制内皮损伤和心血管疾病进展中的作用.
主要方法:
- 对GLP-1RAs和心血管结果研究的文献综述.
- 对GLP-1RA作用机制的研究分析,重点是内皮功能.
- 检查对新陈代谢和肠道微生物群的间接影响.
主要成果:
- GLP-1RAs表现出抗高血压和抗动脉样硬化作用.
- 对冠状动脉血管内皮的直接作用包括减少氧化应激和增加氧化.
- 间接作用涉及新陈代谢和肠道微生物群的调节,有助于抗动脉样硬化功能.
结论:
- GLP-1RAs对内皮功能和心血管健康产生积极影响.
- 需要进一步的研究来阐明特定的细胞点和信号通路.
- GLP-1RAs在治疗心血管疾病方面表现有前途,特别是在内皮功能障碍的背景下.
更多相关视频
相关概念视频
Glucagon-like Receptor Agonists
365
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
365
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Coronary Artery Disease I: Introduction
25
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25
Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
GPCRs Regulate Adenylyl Cylase Activity
5.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K
Regulation of the Cardiovascular System
1.2K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.2K


